OD EXPERT GROUP

Established in 2020 the European Expert Group on Orphan Drug Incentives (OD Expert Group) brings together representatives of the broad rare diseases community, including researchers, academia, patient representatives, members of the investor community, rare disease companies and trade associations... Through a series of workshops, consultations, and as a result of a collaborative effort, the OD Expert Group has developed through the years its proposals for a European HTA fit for Rare Diseases, capable of addressing the key challenges linked to medicinal products for rare and ultra-rare condition. In 2023, during our event, the OD Expert Group officially launched its reports on HTA... The multidisciplinary and cross-functional expert group brings together representatives of the broad rare disease community, including researchers, academia, patient representatives, members of the investor community, rare disease companies, and trade associations. The Group aspires to become a reliable..

Primary location: München Czech Republic